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Abstract c-Ski is an evolutionary conserved protein that is
involved in diverse cellular processes such as proliferation,
differentiation, transformation, and tumor progression. A large
range of cellular partners of c-Ski, including transcription
factors, chromatin-remodeling molecules, tumor suppressors,
and nuclear hormone receptors, has been identified. Moreover,
numerous mechanisms have been described by which c-Ski
regulates essential signaling pathways, e.g., the TGFβ
pathway. In this review, we summarize the diverse roles
attributed to c-Ski during normal development and in cancer
progression and discuss future strategies to unravel further the
complex nature of c-Ski actions in a context-dependent
manner.
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Introduction
The Ski oncogene was first identified as the transforming
protein (v-Ski) of the avian Sloan-Kettering viruses that
induce transformation of chicken embryo fibroblasts (Li et
al. 1986; Stavnezer et al. 1986). The retroviral v-Ski was
subsequently shown to be a truncated version of the coding
exons of the chicken cellular homolog c-Ski (Grimes et al.
1992; Stavnezer et al. 1989; Sutrave and Hughes 1989). To
date, orthologs of this evolutionarily conserved gene have
been identified in human (Nomura et al. 1989), Xenopus
(Amaravadi et al. 1997; Sleeman and Laskey 1993), mouse
(Lyons et al. 1994; Namciu et al. 1995), axolotl (Ludolph et
al. 1995), tilapia (Huang et al. 1999), zebrafish (Kaufman et
al. 2000), and Drosophila (Barrio et al. 2007) (Fig. 1a).
Northern blot analyses have revealed that c-Ski is expressed
as two major mRNAs of different size but constant ratio in
all examined species, such as chicken (Li et al. 1986),
various human cell lines (Nomura et al. 1989), Xenopus
(Sleeman and Laskey 1993), and mouse (Lyons et al.
1994). The basis for the difference between the two
mRNAs is unknown, but studies on chicken (Grimes et al.
1993) and mouse (Lyons et al. 1994) mRNAs indicate that
it is not the result of alternative splicing within the protein
coding region.
Structure of c-Ski
The c-Ski protein contains several structural domains that
mediate protein-protein interactions (Fig. 1b). The amino
(N)-terminal half of c-Ski is a highly conserved segment
comprising two distinct domains (Fig. 1c). The more
conserved of these, the Dachshund homology domain
(DHD; Kim et al. 2002), defines the Ski gene family, which
includes Ski (Stavnezer et al. 1989; Sutrave and Hughes
1989; Wilson et al. 2004), SnoN (Nomura et al. 1989;
Nyman et al. 2010; Pearson-White and Crittenden 1997),
Dach (Davis et al. 1999; Hammond et al. 1998; Kozmik et
al. 1999; Wu et al. 2003), Fussel-15 (Arndt et al. 2007),
Fussel-18 (Arndt et al. 2005), and Corl (Mizuhara et al.
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2005). Based on the analysis of the crystal structure, the
DHD of human c-Ski adopts a mixed α/β structure (Wilson
et al. 2004) that resembles features found in the forkhead/
winged-helix family of DNA-binding proteins (Kim et al.
2002). However, striking differences are present in the
surface properties between Ski-DHD and the DNA-binding
surface described for the Dachshund protein, suggesting
that c-Ski is unlikely to contact DNA via its DHD (Wilson
et al. 2004). The second conserved region comprises the
SAND domain (named after Sp100, AIRE-1, NucP41/75,
and DEAF-1), which is an evolutionarily conserved
sequence motif found in a number of nuclear proteins
involved in chromatin-dependent transcriptional regulation
(Wu et al. 2002). The SAND domain uses an interaction
loop (I-loop) to interact with both protein and DNA.
However, the lack of the critical DNA-binding motif in the
Ski-SAND domain suggests that the I-loop in c-Ski is
primarily a protein-binding segment (Wu et al. 2002). The
carboxyl (C)-terminal half of c-Ski shows less sequence
similarity among the family members (Fig. 1b). This region is
predicted to contain an extended alpha-helical segment
(coiled-coil domain) made up of a tandem repeat and a
leucine zipper-like motif that cooperatively mediate both
homodimerization of c-Ski and the formation of heterodimers
with the related protein SnoN (Cohen et al. 1999; Heyman
and Stavnezer 1994; Nagase et al. 1993; Sleeman and Laskey
1993; Zheng et al. 1997; Fig. 2). Ski and its closest family
member SnoN share extensive sequence homology with
similar domain structures. However, together with a certain
degree of functional similarity, these closely related family
members also display substantial functional and regulatory
differences (for detailed reports on SnoN, see Jahchan and
Luo 2010; Pot et al. 2010; structural and functional
similarities/differences of c-Ski and SnoN have been
reviewed by Deheuninck and Luo 2009; Luo 2004).
Cellular partners of c-Ski
Purified, bacterially synthesized, human c-Ski has been shown
only to bind DNA cellulose when mixed with nuclear extracts
of mammalian cultured cells (Nagase et al. 1990), suggesting
that c-Ski binds DNA only in association with other proteins.
The search for the unknown nuclear factors has led to
the identification of a large number of transcription factors
and transcriptional co-regulators that interact with distinct
structural domains of c-Ski (Fig. 2). In yeast two-hybrid
screens with v-Ski as bait, the Ski-interacting protein (Skip)
has been identified and subsequently found to interact with
the N-terminal region of c-Ski (Dahl et al. 1998b; Prathapam
et al. 2001). Ishii and co-workers have used human c-Ski
sequences as bait and found that c-Ski directly binds to
the co-repressors N-CoR (nuclear receptor co-repressor),
SMRT (silencing mediator for retinoid and thyroid hormone
receptors), and mSin3A and forms a complex with histone
deacetylase 1 (HDAC1; Nomura et al. 1999). A number of
subsequent studies from the same laboratory have revealed
that c-Ski also directly interacts with retinoblastoma protein
(Rb; Tokitou et al. 1999), methyl-CpG-binding protein
(MeCP2; Kokura et al. 2001), promyelocytic leukemia
protein (PML; Khan et al. 2001), glioblastoma proteins
(Gli; Dai et al. 2002), C184M protein (Harada et al. 2003),
and co-repressor homeodomain-interacting protein kinase 2
(HIPK2; Harada et al. 2003). Moreover, work from other
groups have established the direct binding of c-Ski to
members of the nuclear factor I (NFI) family (Tarapore et
al. 1997) and to the transcription factors c-Jun (Pessah et al.
2002) and PU.1 (Ueki et al. 2008). In addition, c-Ski has
been shown to form protein complexes with p53 and the
histone deacetylase SIRT1 (Inoue et al. 2011) and with the
retinoic acid receptor (RARα; Dahl et al. 1998a; Ritter et al.
2006) and the vitamin D receptor (VDR; Ueki and Hayman
2003b). The most extensively investigated interactions,
however, concern the association of c-Ski with Smad proteins
(Akiyoshi et al. 1999; Luo et al. 1999; Sun et al. 1999a; Ueki
and Hayman 2003a; Xu et al. 2000).
Taken together, most of the described interactions have
been detected with purified, bacterially expressed proteins
and have been further confirmed in cell lines under
Fig. 1 Phylogenic relationship and domain organization of the Ski
protein. a Ski protein sequences from various species were aligned by
using ClustalW (http://align.genome.jp/). Accession numbers used in this
multiple aligment are as follows: Drosophila dSki (D. melanogaster):
A0PVD0, zebrafish SkiB (S. rerio): Q9YI02, fish tSki2 (I. tilapia):
Q9PU32, zebrafish SkiA (S. rerio): Q9YI03, fish tSki1 (I. tilapia):
Q9PU31, mouse c-Ski (M. musculus): B1AUF1, human C-Ski (H.
sapiens): P12755, chicken v-ski (A. erythr. virus): P17863, chicken c-ski
(G. gallus): P49140, Xenopus c-Ski (X. laevis): Q02225. A dendrogram
tree was then constructed from the aligned protein sequences. b
Representations showing domain organization of the Ski proteins in
various species. The Dachshund homology, the SAND-like, and the coil-
coiled domains of the Ski proteins are shown. The amino-acid boundaries
of each domain were retrieved from Pfam (http://pfam.sanger.ac.uk/).
Phosphorylation sites of the human ski protein (described in Band et al.
2009; Nagata et al. 2010) and putative phosphorylation sites (predicted by
using NetPhos 2.0 server) are indicated. Note that the short isoform of the
Drosophila dSki is depicted. The length in amino-acids of each sequence
is indicated right. c Ski sequences encoding the Dachshund homology
domain and the SAND-like domain of each species were aligned by using
ClustalW. Highlighted amino-acids indicate a difference compared with
the amino-acids in the mouse c-Ski sequence. The amino-acid boundaries
are indicated for the mouse c-Ski sequence. The crystal structure of the
Dachshund homology domain of human Ski (Wilson et al. 2004) is
indicated in purple. The crystal structure of a human Smad4-Ski complex
(Wu et al. 2002) is also shown in which the Smad4 tumor suppressor C-
terminal domain (chains C and D) is in blue, and the Smad4-binding
domain of Ski (chains A and B) is in pink. Crystal structures generated by
using the Jmol application were retrieved from the RCSB protein
databank (http://www.pdb.org/pdb/home/home.do) by using the following
PDB IDs: 1sbx (Dachshund homology domain of human Ski) and 1mr1
(Smad4-Ski complex)
b
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overexpression conditions (Fig. 2). The challenging task in
the future will be to dissect which interactions with known
and not yet identified cellular partners take place in vivo
under physiological conditions, in distinct cell-types,
tissues, and organs, both during embryonic development
and in adult organisms.
c-Ski function in signaling pathways
c-Ski acts in combination with a number of cellular partners
and, thus, has been shown to be involved in many signaling
pathways, including those mediated by transforming
growth factor β (TGFβ), nuclear hormone receptors, and
Sonic hedgehog (Shh).
TGFβ signaling
The best-characterized function of c-Ski is to regulate TGFβ
signaling negatively via interaction with Smad proteins.
Binding of TGFβ to its receptor serine/threonine kinases
results in the phosphorylation of the receptor-regulated
Smad2 and Smad3 (R-Smad) proteins. The phosphorylated
R-Smads then form heteromeric complexes with a common
mediator Smad4 (Co-Smad). Together, they translocate into
the nucleus, where they bind to DNA and activate the
transcription of target genes. The inhibitory Smad6 and
Smad7 (I-Smad) proteins block R-Smad phosphorylation,
and eventually TGFβ signaling, through a negative feedback
loop. A number of mechanisms have been described that
may contribute to the repression of Smad function by c-Ski
(Fig. 3). Initially, concomitant studies converged on the
conclusion that c-Ski binds to activated Smad2/3/4 hetero-
meric complexes and represses their ability to activate TGFβ
target genes (Akiyoshi et al. 1999; Luo et al. 1999; Sun et al.
1999a; Suzuki et al. 2004; Ueki and Hayman 2003a; Xu et
al. 2000). R-Smads and Co-Smad proteins have been
demonstrated to bind to different regions in c-Ski (Fig. 2a;
Akiyoshi et al. 1999; Luo et al. 1999; Qin et al. 2002), and
mutations of both regions markedly impair the ability of c-
Ski to repress TGFβ-induced transcriptional activation (He
et al. 2003). Akiyoshi et al. (1999) have reported that c-Ski
exclusively associates with TGFβ/activin-specific regulatory
Smad2 and Smad3, but not with bone morphogenetic protein
(BMP)-specific regulatory Smad1 and Smad5 proteins.
These results differ from those of other groups demonstrating
that c-Ski also interacts weakly with the BMP-Smads and
represses BMP signaling (Barrio et al. 2007; Harada et al.
2003; Wang et al. 2000). Subsequent studies have shown that
the interaction of Ski with Smad4 is indispensable for the
suppression of BMP but not TGFβ signaling (Takeda et al.
2004). Analysis of the crystal structure of a Ski fragment
bound to Smad4 has identified the Smad4-binding domain of
c-Ski as a structural homolog of the SAND-like domain (Wu
et al. 2002; Fig. 1b, c). This study has led to the proposal that
c-Ski and the R-Smads compete for mutually exclusive
binding to Smad4/R-Smad complexes (Wu et al. 2002),
suggesting that the Smad complex is disrupted or inactivated
in the presence of c-Ski (Ueki and Hayman 2003a; Wu et al.
2002). In these first reports, c-Ski was proposed to recruit co-
repressors, such as HDAC1 (Akiyoshi et al. 1999) and N-CoR
(Luo et al. 1999) to Smad complexes to mediate transcrip-
tional repression of TGFβ-induced signaling. However,
subsequent studies with a Ski mutant lacking N-CoR binding
instead suggest that the c-Ski/N-CoR interaction is not
essential for the repression of TGFβ signaling (Ueki and
Hayman 2003b). Further findings have revealed that c-Ski
competes with co-activators, such as CREB-binding protein
(CBP) and p300 for binding to Smad3, supporting the
evidence that c-Ski plays an essential role in influencing co-
repressor and co-activator activities on target promoters
(Akiyoshi et al. 1999; Chen et al. 2007). A number of reports
have described additional modes of c-Ski actions. For
example, the C184M protein induces the cytoplasmic accu-
mulation of c-Ski, and the C184M/c-Ski complex negatively
regulates TGFβ signaling by inhibiting the nuclear transloca-
tion of Smad2 (Kokura et al. 2003). Other regulatory roles
assigned to c-Ski are the prevention of the phosphorylation of
Smad2/3, thereby silencing Smad signaling (Prunier et al.
2003), or the direct binding to TGFβ receptor I (TβRI) and
possibly interference with nuclear translocation of the R-
Smad/Smad4 complex (Ferrand et al. 2010). Moreover, c-Ski/
c-Jun protein complexes have been reported to suppress
Smad2 transcriptional activity, thereby participating in nega-
tive feedback regulation of TGFβ signaling by the c-Jun N-
terminal kinase (JNK) cascade (Pessah et al. 2002). In gastric
cancer cells, the association of c-Ski with another co-
repressor, MEL1 (MDS1/EVI1-like gene 1), has been
demonstrated to inhibit TGFβ signaling by stabilizing the
inactive c-Ski/Smad3 complex on target genes (Takahata et al.
2009). Finally, c-Ski has been shown to inhibit the expression
of the inhibitory Smad7 by associating with Smad proteins,
HDAC3, and protein arginine methyltransferase 5 (PRMT5)
on the Smad7 gene promoter (Band et al. 2009; Denissova
and Liu 2004; Tabata et al. 2009).
Nuclear hormone receptor signaling
In addition to modulating the TGFβ pathway, c-Ski appears
to play a major role in nuclear hormone receptor signaling
Fig. 2 Cellular partners of c-Ski. a Ski domains required for
association with the indicated partner proteins are depicted. b
Summary of the binding partners of the Ski protein. Ski-binding
domains implicated in direct interaction are indicated but are
otherwise mentioned as “complex” when no direct binding has been
established

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via its established direct interaction with the co-repressors N-
CoR/SMRT and mSin3A and by its association with HDAC1
(Nomura et al. 1999). Members of the nuclear hormone
receptor family, such as thyroid hormone receptor (TR), RAR,
and VDR, regulate gene expression in a ligand-dependent
fashion, thereby actively repressing the transcription of target
genes in the absence of ligand. The repressor function of TR
is mediated by protein complexes including N-CoR/SMRT,
mSin3A, HDAC, and another repressor, Mad, which bind to
the ligand-binding domain of TR to enable transcriptional
repression. Nomura et al. (1999) have discovered that the
presence of c-Ski is required for the negative transcriptional
activity of Mad and TRβ on target sequences, such as the
gene for ornithine decarboxylase. Similarly, c-Ski has been
shown to associate with the RAR and VDR complex,
including N-CoR/SMRT and HDAC, and represses transcrip-
tion from a retinoic acid response element (Dahl et al. 1998a;
Khan et al. 2001; Zhao et al. 2009, 2010) and a VDR-
responsive promoter (Ueki and Hayman 2003b), respectively.
In support of this finding, a mutant c-Ski unable to bind N-
CoR was no longer capable of repressing RARα (Ritter et al.
2006) or vitamin D (Ueki and Hayman 2003b) function.
Notably, c-Ski/N-CoR interaction appears to be essential for
the repression of nuclear hormone receptor signaling but not
TGFβ signaling (Ueki and Hayman 2003b). Thus, depending
on the signaling pathway, c-Ski appears to use distinct modes
of repression, through N-CoR-dependent and -independent
mechanisms.
Shh signaling
c-Ski has also been reported to bind directly to Gli proteins (Dai
et al. 2002). Members of the Gli family of transcriptional
regulators (Gli1, Gli2, and Gli3) are the intracellular mediators
of Shh signaling. Shh upregulates Gli1 transcription but
downregulates Gli3 expression. Molecular analysis has
revealed that Gli3 is processed into a repressor form that
suppresses the Gli1 promoter. Dai et al. (2002) have
demonstrated that c-Ski interacts with the repressor domain
located in the N-terminal region of Gli3, recruits the HDAC
complex, and inhibits Shh-induced Gli1 gene transcription;
this study has established that the presence of c-Ski is
mandatory for transcriptional repression mediated by the
repressor form of Gli3.
Summary of c-Ski interactions in signaling pathways
The above-described paradigms demonstrate the direct and
indirect interactions of c-Ski with transcription factors (e.g.,
Smads, Gli proteins) including tumor suppressors (e.g., Rb,
Mad), with co-repressors including chromatin remodeling
factors (e.g., N-CoR/SMRT, mSin3A, HDACs), and with
nuclear hormone receptors (e.g., TRβ, RARα, VDR) to
regulate various signaling pathways (Fig. 2). Thus, numerous
findings have established c-Ski as an essential molecule that
links transcription factors and nuclear receptors to co-repressor
complexes or that stabilizes and enhances the activity of
repressor complexes on DNA sequences. Furthermore, c-Ski
not only acts as a co-repressor, but also seems to employ
additional mechanisms for transcriptional regulation, such as
preventing transcription factors from binding to DNA (i.e.,
GATA1, p53; Inoue et al. 2011; Ueki et al. 2004) or promoting
transcription of target genes as a co-activator of NFI or the
four-and-a-half LIM domain protein 2 (LIM-only protein
FHL2) (Chen et al. 2003; Tarapore et al. 1997). Notably, c-
Ski has also been shown to localize at centrosomes and the
mitotic spindle, suggesting that it might play a role during
mitosis, in addition to its known role in transcription
(Marcelain and Hayman 2005).
c-Ski in cancer progression
c-Ski was originally discovered as the cellular homolog of the
retroviral v-Ski and was thus classified as a proto-oncogene.
Indeed, subsequent studies showed that the overexpression of
c-Ski promoted the oncogenic transformation of avian
fibroblasts (Colmenares et al. 1991a). Supporting this notion,
protein expression of c-Ski is elevated in many human
cancer cells and tissues (Fig. 4), including those obtained
from patients suffering from esophageal squamous cell
Fig. 3 Various mechanisms of modulation of TGFβ signaling by
c-Ski (for an explanation of abbreviations see Fig. 2b). 1 c-Ski
negatively regulates TGFβ signaling by repressing Smad-mediated
transcriptional activation through its interaction with mSin3A,
MeCP2, and HDAC (Akiyoshi et al. 1999; Luo et al. 1999; Sun et
al. 1999a; Xu et al. 2000; Ueki and Hayman 2003a). 2 c-Ski inhibits
the TGF-β signaling pathway through stabilization of inactive Smad
complexes on Smad-binding elements; this in turn blocks the access
of newly activated Smad complexes to DNA (Suzuki et al. 2004;
Ueki and Hayman 2003a). 3 Arkadia-mediated degradation of Ski
allows active phospho-Smads binding to DNA (Nagano et al. 2007).
4 c-Ski competes with the co-activators CBP and p300 proteins for
binding to Smad3 (Akiyoshi et al. 1999; Chen et al. 2007). 5 c-Ski/c-
jun complexes suppress Smad2 transcriptional activity (Pessah et al.
2002). 6 c-Ski suppresses the expression of the inhibitory Smad7 by
associating with the Smad proteins, HDAC3 and PRMT5 (Denissova
and Liu 2004; Band et al. 2009; Tabata et al. 2009). 7 MEL1
interacts with c-Ski in gastric cancer cells and cooperates to inhibit
TGFβ signaling by enhancing the Smad3-Ski interaction and by
promoting the binding of Smad3 to the Smad-binding DNA element
(Takahata et al. 2009). 8 The C184M protein induces the
cytoplasmic accumulation of c-Ski, and the C184M-Ski complex
negatively regulates TGFβ signaling by inhibiting the nuclear
translocation of the Smads (Kokura et al. 2003). 9 The interaction
of c-Ski with TβRI suppresses nuclear accumulation of the Smads
complex; this occurs as a consequence of the sequestration of this
complex by TβRI (Ferrand et al. 2010)
b
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carcinoma (Fukuchi et al. 2004), Barrett's esophagus
(Villanacci et al. 2008), leukemia (Ritter et al. 2006),
colorectal cancer (Bravou et al. 2009), gastric cancer
(Takahata et al. 2009), pancreatic cancer (Heider et al.
2007; Wang et al. 2009), hemangiomas (O et al. 2009), and
melanoma (Boone et al. 2009; Reed et al. 2001). Further
evidence supporting the pro-oncogenic function of c-Ski in
tumor progression comes from studies of various human
cancer cell lines (Fig. 4b). For example, the overexpression of
c-Ski in diffuse-type gastric carcinoma cells inhibits TGFβ
signaling and promotes extensive growth of subcutaneous
xenografts in nude mice (Kiyono et al. 2009). In agreement,
the knockdown of c-Ski restores TGFβ responsiveness in
these cells and reduces tumor growth in vivo (Takahata et al.
2009). Similarly, the inhibition of c-Ski through RNA
interference increases TGFβ signaling and growth inhibition
in pancreatic cell lines (Heider et al. 2007; Wang et al. 2009)
and melanoma (Chen et al. 2009; Reed et al. 2001). TGFβ is
not the only pathway that is disturbed because of aberrant c-
Ski expression levels in tumors. Studies of leukemia cell lines
have revealed that the overexpression of c-Ski inhibits the
pro-differentiating effects of RARα signaling in acute
myeloid leukemia (Ritter et al. 2006), and work with
melanoma cells has demonstrated that c-Ski stimulates
growth by associating with the transcriptional modulators
FHL2 and β-catenin and by activating the Wnt signaling
pathway (Chen et al. 2003). Further, a recent study has
reported that c-Ski interacts with p53 and attenuates the
biological functions of this tumor suppressor (Inoue et al.
2011). Interestingly, c-Ski has been found to bind the histone
deacetylase SIRT1 and stabilize the p53-SIRT1 interaction to
promote p53 deacetylation, which subsequently decreases the
DNA-binding activity of p53 (Inoue et al. 2011). These
results, however, contradict findings proposing that c-Ski acts
as a tumor suppressor in some cancer cells (Le Scolan et al.
2008). In support of these results, the loss of one copy of c-
Ski leads to increased susceptibility to carcinogen-induced
tumors in mice (Shinagawa et al. 2001). Further, c-Ski
represses the oncogenic activation of c-Myb (Nomura et al.
2004) and acts as a co-repressor of tumor suppressors such as
Rb (Tokitou et al. 1999) and Mad (Nomura et al. 1999).
In conclusion, the physiological levels of c-Ski appear to
protect cells from transformation, whereas high expression
levels of c-Ski in cancer cells and tumors promote growth by
modulating antiproliferative (e.g., TGFβ, RAR) and prolifer-
ative (e.g., Wnt) signals. Additionally, aberrant cellular
localization might contribute to the pro-oncogenic function
of c-Ski. Originally, c-Ski was identified as a nuclear protein
(Barkas et al. 1986; Colmenares et al. 1991a; Sutrave et al.
1990a), and more recent work has identified a nuclear
localization signal in human c-Ski (Nagata et al. 2006).
However, in tumor cells of virtually all analyzed specimens,
c-Ski is reported to localize also to the cytoplasm, which
might enhance its growth-promoting properties (Bravou et al.
2009; Fukuchi et al. 2004; Heider et al. 2007; Reed et al.
2001; Villanacci et al. 2008). Mechanisms employed by
cytoplasmic c-Ski, such as the promotion of cell proliferation
by sequestering the tumor suppressor Rb to the cytoplasm
(Jacob et al. 2008) or the inhibition of TGFβ signaling by
interfering with its cytoplasmic intermediates (Ferrand et al.
2010; Kokura et al. 2003; Prunier et al. 2003), have been
proposed (Fig. 3). Whether such modes of action also take
place in tumor cells remains to be seen. The mechanisms
leading to elevated c-Ski expression in cancerous cells,
however, continue to be elusive. Indeed, no data is available
on the transcriptional regulation of c-Ski. Possibly the
degradation pathways affecting c-Ski expression levels (Le
Scolan et al. 2008; Macdonald et al. 2004; Nagano et al.
2007; Sun et al. 1999b) are differently regulated in tumor
cells, contributing to the high expression levels of c-Ski
(Nagano et al. 2010). Further, an amplification of the Ski
gene locus, as discovered in colorectal cancer cells, might
also account for the higher expression levels in other types of
tumors (Buess et al. 2004). Alternatively, extracellular and
intracellular cues that are aberrantly active in tumor tissue
might lead to a deregulation of c-Ski protein expression.
c-Ski function during normal development
c-Ski transcripts are widely distributed in various species
and organs, and based on extensive in vivo studies, critical
roles in muscle and nervous system development have been
attributed to c-Ski function. In Xenopus, c-Ski transcripts
are maternally regulated and present throughout early
development (Sleeman and Laskey 1993). Overexpression
of Xenopus c-Ski RNA in embryos results in cell-
autonomous induction of secondary neural axis formation
and neural-specific gene expression in ectodermal explants
(Amaravadi et al. 1997; Wang et al. 2000). In zebrafish,
overexpression of SkiA or SkiB disrupts gastrulation and
results in a dorsalized phenotype. In particular, this study
suggests a role of c-Ski proteins in neural patterning
(Kaufman et al. 2000). In mouse, c-Ski transcripts are
detectable in most embryonic tissues at low levels, with the
highest c-Ski message expression being found in brain and
lung (Lyons et al. 1994; Namciu et al. 1995). Accordingly,
mice lacking c-Ski display highly pleiotropic defects
including aberrant neural, ocular, and muscle development
(Berk et al. 1997; McGannon et al. 2006; Shinagawa and
Ishii 2003). Pups suffer from exencephaly attributable to
Fig. 4 c-Ski and cancer. a Summary showing human tumor tissues in
which c-Ski expression is elevated. b Summary of the effects of the
over-expression or knock-down (KD) of c-Ski on TGFβ (yellow),
RARα (blue), Wnt (pink), and p53 (green) signaling in various human
cancer cell lines

58 Cell Tissue Res (2012) 347:51–64
Cell Tissue Res (2012) 347:51–64 59
failed neural tube closure and die perinatally. The penetrance
of the phenotypes is strain-dependent, yielding mutant fetuses
that display facial clefting and other craniofacial and skeletal
abnormalities of varying severity (Colmenares et al. 2002).
Additionally, we have shown that myelinating Schwann
cells, the main glial cells of the peripheral nervous system,
express c-Ski protein in vivo, and that, in c-Ski-deficient
sciatic nerves, Schwann cells fail to upregulate genes
encoding myelin components (Atanasoski et al. 2004).
Consistent with these findings, loss of c-Ski prevents
myelination in vitro, whereas enforced c-Ski expression
promotes the expression of myelin-related genes in Schwann
cells (Atanasoski et al. 2004). c-Ski-deficient mice also show
a strong decrease in skeletal muscle mass (Berk et al. 1997).
Conversely, transgenic mice that express high levels of
ectopic c-Ski in skeletal muscle display hypertrophy of fast
skeletal muscle fibers (Lana et al. 1996; Leferovich et al.
1995; Sutrave et al. 1990b, 2000). Previous studies have
indicated the essential function of c-Ski in myogenesis.
Overexpression of c-Ski in cultured avian fibroblasts induces
terminal differentiation of muscle cells (Colmenares and
Stavnezer 1989), and ectopic expression of c-Ski in various
muscle cell lines triggers the expression of muscle-specific
genes (Colmenares et al. 1991b; Engert et al. 1995; Ichikawa
et al. 1997; Kobayashi et al. 2007; Zhang and Stavnezer
2009). In addition to muscle and neuronal lineages, c-Ski
modulates the differentiation of hematopoietic cells (Dahl et
al. 1998a; Pearson-White et al. 1995; Ueki et al. 2004, 2008)
and fibroblasts (Cunnington et al. 2011; Jinnin et al. 2007;
Liu et al. 2008; Marcelain et al. 2011) in vitro. Notably, the
expression of c-Ski is altered under many pathological
conditions, including demyelinated or injured peripheral
nerves (Atanasoski et al. 2004), wound healing (Li et al.
2011; Liu et al. 2010), liver regeneration (Macias-Silva et al.
2002), and skeletal muscle regeneration (Soeta et al. 2001).
Finally, the symptoms of the human genetic disorder 1p36
syndrome mirror the phenotypes of Ski-deficient mice,
suggesting that the deletion of the c-Ski gene located on
chromosome 1p36.3 is partially responsible for the disease
(Colmenares et al. 2002; Rosenfeld et al. 2010).
In summary, these findings suggest a cell-type specific
function for c-Ski with regard to the regulation of proliferation
and differentiation processes during normal development.
Based on the large set of available biochemical data, the
physiological role of c-Ski might be closely related to the
presence or absence of interaction partners at distinct
developmental stages, controlling cell type-specific down-
stream target genes. In addition, the function of c-Ski within a
given cell type might even vary during the course of
development, because of environmental changes caused by
temporally and regionally restricted expression of signaling
cues, including members of the TGFβ family, retinoic acid,
Wnt, or Shh.
Future directions
Numerous studies in healthy and diseased cells have made
evident that the expression levels of c-Ski strongly impact the
molecular and cellular machinery of distinct cell types. Thus,
detailed analyses of the spatial and temporal distribution of the
c-Ski protein during organogenesis and in the adult will be
mandatory to discover cell-type and stage-specific expression
patterns. Such information will provide a basis for elucidating
the complex physiological roles of c-Ski. The low expression
levels of endogenous c-Ski protein and/or the lack of suitable
anti-Ski antibodies have greatly hampered such progress.
Novel tools and strategies will have to be developed to improve
our knowledge of endogenous c-Ski expression and of
candidate partners in a context-dependent manner. Moreover,
in view of the large range of proposed cell-type-specific
functions for c-Ski, new animal models will have to be
generated to enable conditional and cell-type-specific c-Ski
ablation. Such approaches will greatly facilitate the dissection
of the cell-autonomous functions of c-Ski in health and disease.
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